Literature DB >> 2697558

Presence of peroxisomal membrane proteins in liver and fibroblasts from patients with the Zellweger syndrome and related disorders: evidence for the existence of peroxisomal ghosts.

E A Wiemer1, S Brul, W W Just, R Van Driel, E Brouwer-Kelder, M Van Den Berg, P J Weijers, R B Schutgens, H Van Den Bosch, A Schram.   

Abstract

The presence and intracellular localization of peroxisomal integral membrane proteins (PMP) were investigated in liver and cultured skin fibroblasts from control subjects and patients with the Zellweger syndrome and related disorders in which peroxisomes are virtually absent. Immunoblotting experiments showed that 22, 36 and 69 kDa PMPs were present and were confined to the membranous fraction both in the control liver and in the livers from the Zellweger patients. The 22 and 36 kDa PMPs were present in significantly lower amounts in the patients' livers than in the control liver. A reduced amount of the 69 kDa PMP was found in liver from one Zellweger but not in liver from another. The subcellular localization in fibroblasts of catalase and the 69 kDa PMP was studied by indirect immunofluorescence. A characteristic punctate fluorescence was seen in control cells incubated with either anti-(catalase) or with anti-(69 kDa PMP). Incubation of mutant cells with anti-(catalase) resulted in a diffuse fluorescence, whereas with anti-(69 kDa PMP) fluorescent particles were visualized which, in some cell lines, were larger and fewer in number than in control cells. Cryosections of control and mutant cells were examined by electron microscopy using immunogold labeling. Control cells contained small structures consisting of a single membrane enclosing a homogeneous matrix; the membranes reacted with anti-(69 kDa PMP) and the matrix with anti-(catalase). The mutant cell lines contained spherical or ellipsoidal structures whose membranes reacted with anti-(69 kDa PMP); no labeling was observed with anti-(catalase). We conclude that peroxisomal ghosts, the membranes of which contain the 69 kDa PMP, are present in peroxisome-deficient cell lines from all complementation groups studied so far.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2697558

Source DB:  PubMed          Journal:  Eur J Cell Biol        ISSN: 0171-9335            Impact factor:   4.492


  26 in total

1.  Complementation study of peroxisome-deficient disorders by immunofluorescence staining and characterization of fused cells.

Authors:  S Yajima; Y Suzuki; N Shimozawa; S Yamaguchi; T Orii; Y Fujiki; T Osumi; T Hashimoto; H W Moser
Journal:  Hum Genet       Date:  1992-03       Impact factor: 4.132

2.  Prenatal diagnosis of Zellweger syndrome by direct visualization of peroxisomes in chorionic villus fibroblasts by immunofluorescence microscopy.

Authors:  R J Wanders; E A Wiemer; S Brul; R B Schutgens; H van den Bosch; J M Tager
Journal:  J Inherit Metab Dis       Date:  1989       Impact factor: 4.982

3.  Role of pH in determining the cell-type-specific residual activity of glucocerebrosidase in type 1 Gaucher disease.

Authors:  S van Weely; M van den Berg; J A Barranger; M C Sa Miranda; J M Tager; J M Aerts
Journal:  J Clin Invest       Date:  1993-03       Impact factor: 14.808

4.  Effects of fixation on the preservation of peroxisomal structures for immunofluorescence studies using HepG2 cells as a model system.

Authors:  M Schrader; E Baumgart; H D Fahimi
Journal:  Histochem J       Date:  1995-08

5.  Immunoblot analysis of peroxisomal proteins in liver and fibroblasts from patients.

Authors:  R J Wanders; C Dekker; R Ofman; R B Schutgens; P Mooijer
Journal:  J Inherit Metab Dis       Date:  1995       Impact factor: 4.982

6.  Peroxisome assembly factor 1: nonsense mutation in a peroxisome-deficient Chinese hamster ovary cell mutant and deletion analysis.

Authors:  T Tsukamoto; N Shimozawa; Y Fujiki
Journal:  Mol Cell Biol       Date:  1994-08       Impact factor: 4.272

7.  Presence of cytoplasmic factors functional in peroxisomal protein import implicates organelle-associated defects in several human peroxisomal disorders.

Authors:  M Wendland; S Subramani
Journal:  J Clin Invest       Date:  1993-11       Impact factor: 14.808

8.  Mutation in PEX16 is causal in the peroxisome-deficient Zellweger syndrome of complementation group D.

Authors:  M Honsho; S Tamura; N Shimozawa; Y Suzuki; N Kondo; Y Fujiki
Journal:  Am J Hum Genet       Date:  1998-12       Impact factor: 11.025

9.  Morphometry of peroxisomes and immunolocalization of peroxisomal proteins in the liver of patients with generalised peroxisomal disorders.

Authors:  J L Hughes; D I Crane; E Robertson; A Poulos
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1993

Review 10.  Liver pathology and immunocytochemistry in congenital peroxisomal diseases: a review.

Authors:  F Roels; M Espeel; D De Craemer
Journal:  J Inherit Metab Dis       Date:  1991       Impact factor: 4.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.